nav-left cat-right
cat-right

InnoVet Selects EBD Group to Power its Conference ...

Carlsbad, CA , October  09, 2007 –  EBD Group, the leading partnering firm for the global biotechnology industry, today announced that it has been selected to run the partnering facility for InnoVet 2007, the premier international veterinary business conference and partnering event held this year in Charlottetown, Prince Edward Island, Canada, October 14-16, 2007.  InnoVet will use EBD Group’s...

BIOSERVE and DNAPRINT(R) GENOMICS FORM STRATEGIC A...

BioServe’s fully annotated clinical samples across many diseases to be tagged with ancestry information using DNAPrint’s genetic ancestry tests BELTSVILLE, MD., Oct. 9, 2007 – BioServe today announced the formation of strategic alliance with DNAPrint® Genomics, Inc. (OTCBB: DNAG) to provide biomedical researchers with clinical DNA samples that for the first time will include genetic ancestry data for...

BIO-Europe 2007 Plays Host to the Largest Number o...

Munich, Germany, and Washington D.C., Sept. 17, 2007 – Globalization is the nature of the life sciences industry. EBD Group and the Biotechnology Industry Organization (BIO) announce that BIO-Europe 2007 will include an even greater number of international delegations of biotech companies seeking strategic biotech partnerships than previous years. “We are very pleased that delegations from so many...

Cisbio has entered into a partnership agreement wi...

The agreement grants Cisbio exclusive access to the Lumi4 compounds for fluorescence applications in drug discovery, with Lumiphore free to develop partnerships to develop the technology in other areas. Cisbio has played an important part in the development of HT drug screening technologies and has enabled researchers to conduct binding assays based on its homogenous time-resolved fluorescence (HTRF) system that combines...

Tikvah Therapeutics, Inc. And Chakra Biotech Pte. ...

SINGAPORE, Norway, Sept 6, 2007 – (Hugin via ACN Newswire) – ATLANTA and SINGAPORE, Sept. 6, 2007 (PRIME NEWSWIRE) — Tikvah Therapeutics, Inc., a biopharmaceutical company focused on new treatment options to better manage central nervous system diseases, and Chakra Biotech Pte. Ltd., a drug discovery and development company focusing on central nervous system disorders, yesterday announced a collaboration and...

BioServe and Phenomenome Discoveries Develop Novel...

Laurel, MD and Saskatoon, SK, Canada, August 6, 2007 – BioServe and Phenomenome Discoveries Inc. (“PDI”) today announced that they have developed a novel serum-based diagnostic test for the identification of colorectal cancer (CRC), and pre-cancerous states conducive to the development of CRC. Colorectal cancer comprises a tenth of the global cancer burden, and is the third most common malignancy in...
Page 20 of 31« First...10...1819202122...30...Last »